MiR-106a directly targets LIMK1 to inhibit proliferation and EMT of oral carcinoma cells.

Conclusion: MiR-106a inhibited the cell proliferation and EMT of OSCC cells by directly decreasing LIMK1 expression. PMID: 30873211 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30873211?dopt=Abstract

Source: Cellular and Molecular Biology Letters - March 17, 2019 Category: Biochemistry Authors: Shi B, Ma C, Liu G, Guo Y Tags: Cell Mol Biol Lett Source Type: research